跳至主要内容
临床试验/NCT07845162
NCT07845162尚未招募不适用

Serum Epstein-Barr Virus-induced Gene 3 Protein Levels in Patients With Behçet's Disease

Assiut University0 个研究点目标入组 90 人开始时间: 2026年9月26日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
90
主要终点
Mean serum EBI-3 protein level

研究概览

简要总结

This cross-sectional study aims to evaluate serum Epstein-Barr virus-induced gene 3 (EBI-3) protein levels in patients with Behçet's disease compared with healthy controls.

详细描述

Behçet's disease is a chronic multisystem inflammatory disorder. Serum EBI-3 protein levels may reflect inflammatory activity.

This observational study will include adult patients diagnosed with Behçet's disease according to the International Criteria for Behçet's Disease and age-matched healthy controls. Serum EBI-3 protein levels will be measured by ELISA.

研究设计

研究类型
观察性
观察模型
病例对照
时间视角
横断面

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • - Age 18 years or older
  • Diagnosis of Behçet's disease according to the International Criteria for Behçet's Disease (cases)
  • Healthy individuals without autoimmune or inflammatory diseases (controls)
  • Written informed consent

排除标准

  • - Other autoimmune disorders (RA, SLE, psoriatic arthritis, ankylosing spondylitis)
  • Acute or chronic infection
  • Malignancy or history of malignancy
  • Chronic liver disease or advanced chronic kidney disease
  • Pregnancy or lactation
  • Vasculitis caused by diseases other than Behçet's disease

研究组 & 干预措施

Behçet's Disease

Patients diagnosed with Behçet's disease according to the International Criteria for Behçet's Disease.

Healthy Controls

Age-matched healthy individuals without autoimmune or inflammatory diseases.

结局指标

主要结局

Mean serum EBI-3 protein level

时间窗: Baseline

Mean serum Epstein-Barr virus-induced gene 3 (EBI-3) protein concentration measured by ELISA in patients with Behçet's disease compared with healthy controls.

次要结局

  • Serum EBI-3 level according to disease activity(Baseline)
  • Serum EBI-3 level in patients with vascular involvement(Baseline)
  • Serum EBI-3 level in patients with ocular involvement(Baseline)
  • Serum EBI-3 level in patients with neurological involvement(Baseline)

研究者

申办方类型
其他
责任方
主要研究者
主要研究者

Shrouk Samir Mohamed

Resident Physician, Department of Physical Medicine, Rheumatology and Rehabilitation

Assiut University

标识符

NCT 编号
NCT07845162
其他研究编号
EBI3-Behcet-Assiut-2026

日期

首次提交
(8天前)
首次发布
(前天)
主要完成日期
(12个月后)
研究完成日期
(明年)
最近核实
(29天前)
最近更新
(前天)

监管与共享

FDA 监管药物
否
FDA 监管器械
否
个体参与者数据共享计划
否
是否有结果
否

相似试验